Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Zu-wei Wang"'
Autor:
Ge Li, Fei-Fei She, Cheng-Yu Liao, Zu-Wei Wang, Yi-Ting Wang, Yong-Din Wu, Xiao-Xiao Huang, Cheng-Ke Xie, Hong-Yi Lin, Shun-Cang Zhu, Yin-Hao Chen, Zhen-heng Wu, Jiang-Zhi Chen, Shi Chen, Yan-Ling Chen
Publikováno v:
Cell Death and Disease, Vol 15, Iss 10, Pp 1-15 (2024)
Abstract Resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC) leads to ineffective chemotherapy and, consequently, delayed treatment, thereby contributing to poor prognosis. Glycolysis is an important intrinsic reason for gemcitabine
Externí odkaz:
https://doaj.org/article/4bdc36bc2ab14f91b64441e6f98e7ee8
Autor:
Cheng-Ke Xie, Cheng-Yu Liao, Hong-Yi Lin, Yong-Ding Wu, Feng-Chun Lu, Xiao-Xiao Huang, Zu-Wei Wang, Ge Li, Cai-Feng Lin, Jian-Fei Hu, Yin-Hao Chen, Qiao-Wei Li, Li-Qun Chen, Hui-Xing Chen, Shi Chen
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-24 (2024)
Abstract The Nab-paclitaxel combined with gemcitabine (AG) regimen is the main chemotherapy regimen for pancreatic cancer, but drug resistance often occurs. Currently, the ability to promote sensitization in drug-resistant cases is an important clini
Externí odkaz:
https://doaj.org/article/edf2aa10eb904f14b6d7926db16fd850
Autor:
Cheng-Yu Liao, Ge Li, Feng-Ping Kang, Cai-Feng Lin, Cheng-Ke Xie, Yong-Ding Wu, Jian-Fei Hu, Hong-Yi Lin, Shun-Cang Zhu, Xiao-Xiao Huang, Jian-Lin Lai, Li-Qun Chen, Yi Huang, Qiao-Wei Li, Long Huang, Zu-Wei Wang, Yi-Feng Tian, Shi Chen
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-23 (2024)
Abstract Pancreatic ductal adenocarcinoma (PDAC) is a devastating cancer with dismal prognosis due to distant metastasis, even in the early stage. Using RNA sequencing and multiplex immunofluorescence, here we find elevated expression of mixed lineag
Externí odkaz:
https://doaj.org/article/3526e9d64b1549558ff7062b029ca9d4
Autor:
Feng‐Ping Kang, Zhi‐Wen Chen, Cheng‐Yu Liao, Yong‐Ding Wu, Ge Li, Cheng‐Ke Xie, Hong‐Yi Lin, Long Huang, Yi‐Feng Tian, Zu‐Wei Wang, Shi Chen
Publikováno v:
Advanced Science, Vol 11, Iss 16, Pp n/a-n/a (2024)
Abstract Patients with concurrent intrahepatic cholangiocarcinoma (ICC) and hepatolithiasis generally have poor prognoses. Hepatolithiasis is once considered the primary cause of ICC, although recent insights indicate that bacteria in the occurrence
Externí odkaz:
https://doaj.org/article/f4e7d6a785374577a479f7739dacebb9
Autor:
Cai-Feng Lin, Zhi-Wen Chen, Feng-Ping Kang, Jian-Fei Hu, Long Huang, Cheng-Yu Liao, Jian-Lin Lai, Yi Huang, Zu-Wei Wang, Yi-Feng Tian, Shi Chen
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-21 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is considered one of the most common cancers, characterized by low early detection and high mortality rates, and is a global health challenge. Immunogenic cell death (ICD) is defined as a specific ty
Externí odkaz:
https://doaj.org/article/25aaf75054f84788a5a929ce7ac40e49
Autor:
Zhi‐Wen Chen, Feng‐Ping Kang, Cheng‐Ke Xie, Cheng‐Yu Liao, Ge Li, Yong‐Ding Wu, Hong‐Yi Lin, Shun‐Cang Zhu, Jian‐Fei Hu, Cai‐Feng Lin, Yi Huang, Yi‐Feng Tian, Long Huang, Zu‐Wei Wang, Shi Chen
Publikováno v:
Advanced Science, Vol 10, Iss 32, Pp n/a-n/a (2023)
Abstract Intrahepatic cholangiocarcinoma (ICC) is characterized by its dense fibrotic microenvironment and highly malignant nature, which are associated with chemotherapy resistance and very poor prognosis. Although circRNAs have emerged as important
Externí odkaz:
https://doaj.org/article/8ad815b4b506453cb69e0257fa85c7f0
Autor:
Zhi-Wen Chen, Jian-Fei Hu, Zu-Wei Wang, Cheng-Yu Liao, Feng-Ping Kang, Cai-Feng Lin, Yi Huang, Long Huang, Yi-Feng Tian, Shi Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-23 (2022)
Abstract Background Chemoresistance of pancreatic cancer is the main reason for the poor treatment effect of pancreatic cancer patients. Exploring chemotherapy resistance-related genes has been a difficult and hot topic of oncology. Numerous studies
Externí odkaz:
https://doaj.org/article/7531f87a79cd424fb38f8d597e17e0f2
Autor:
Jian-fei Hu, Zu-wei Wang, Cheng-yu Liao, Zhi-wen Chen, Feng-ping Kang, Cai-feng Lin, Tian-sheng Lin, Long Huang, Yi-feng Tian, Shi Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundChimeric antigen receptor-engineered T cell (CAR-T) therapy has shown promising potential for anti-cancer treatment. However, for pancreatic ductal adenocarcinoma (PDAC), the lack of infiltrative ability of these CAR-T cells leads to sub-op
Externí odkaz:
https://doaj.org/article/2148eec4b6ba49a79de5c66018cace8e
Autor:
Shi Chen, Can Yang, Zu-Wei Wang, Jian-Fei Hu, Jing-Jing Pan, Cheng-Yu Liao, Jia-Qiang Zhang, Jiang-Zhi Chen, Yi Huang, Long Huang, Qian Zhan, Yi-Feng Tian, Bai-Yong Shen, Yao-Dong Wang
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-24 (2021)
Abstract Background Both aberrant alternative splicing and m6A methylation play complicated roles in the development of pancreatic cancer (PC), while the relationship between these two RNA modifications remains unclear. Methods RNA sequencing (RNA-se
Externí odkaz:
https://doaj.org/article/01d7197874484cb79bff06aee64ec8cf
Autor:
Jiaqiang Zhang, Jiang-Zhi Chen, Yao-Dong Wang, Qian Zhan, Yi Huang, Long Huang, Jing-Jing Pan, Zu-Wei Wang, Cheng-Yu Liao, Can Yang, Shi Chen, Baiyong Shen, Yifeng Tian, Jian-Fei Hu
Publikováno v:
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-24 (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology
BackgroundBoth aberrant alternative splicing and m6A methylation play complicated roles in the development of pancreatic cancer (PC), while the relationship between these two RNA modifications remains unclear.MethodsRNA sequencing (RNA-seq) was perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae204dd2eaa5798c718475078c1052e
https://doi.org/10.1186/s13045-021-01072-8
https://doi.org/10.1186/s13045-021-01072-8